Pediatric Hematology / Oncology Fellowship Program

Division Chief:
Rajen Mody, M.D., M.S.

Fellowship Director:
Sung Won Choi, M.D., M.S.

Associate Fellowship Directors:
Rama Jasty-Rao, M.D.
Angela Weyand, M.D.

3rd Year Fellows
Tom Michniacki, M.D.
Mark Shamoun, M.D.

2nd Year Fellows
Laura McKay, M.D.
David Svilar, M.D., Ph.D.

1st Year Fellows
Evan Cantor, JD, M.D.
Sarah Koblick, M.D.

The University of Michigan offers highly competitive salaries and tremendous benefits to our residents/fellows. An overview of salary, benefits and employment eligibility is available on the GME Office website, under “Prospective Residents/Fellows.”

Why consider Michigan for your Fellowship?

The University of Michigan and Mott Children’s Hospital are recognized leaders in translating state-of-the-art research to clinical care for children and young adults with hematologic-oncologic disorders. We are a tertiary medical center offering both precision-based medicine and targeted therapeutics (e.g, MIBG therapy, CAR-T therapy, Immunotherapy) to our patients; our genomic sequencing program is internationally recognized. We are the only program in the state designated as a COG Phase I Center for novel therapeutic agents. Our faculty are recognized for their expertise in a wide array of non-malignant and malignant disorders with dedicated research programs in neuro-oncology, neuroblastoma, precision oncology, transplantation / cellular immunotherapy, coagulation disorders, immuno-hematology  and hemoglobinopathies.

The University of Michigan Pediatric Hematology and Oncology (PHO) Fellowship is a three-year program that is specifically oriented toward individuals who will pursue academic careers in hematology, oncology, or BMT/cellular therapy or assume leadership positions in clinical practice.  A centerpiece of our training program is a ten-week “boot camp” course (July-September) that is designed to introduce physicians (without significant research background) who have completed their first year of clinical training to a series of rigorous exercises in problem-solving from the perspective of cell and molecular biology to better prepare them for their research experiences.  Clinical activities occur in one of the leading children’s hospitals in the United States as well as the Rogel Cancer Center, a leading comprehensive cancer center.  The extraordinarily rich research environment, with faculty from departments and institutes throughout the university, provides virtually unlimited opportunities for young scholars in this discipline.  The PHO training program lays the foundation for outstanding future careers, and its graduates become division chiefs, department chairs, leaders in national societies and pioneers who advance both clinical and basic research. Applicants should be dedicated to a career in academic medicine with the intent to develop a career in bench or translational science research in hematology-oncology/BMT/cellular therapy. 

Who are we?

  • 16 faculty members dedicated to research, patient care and fellow education
  • 15 nurse practitioners to support patient care
  • Dedicated social workers, pharmacists, nurses, research coordinators and child life specialists

What do we do?

What makes us unique?

  • COG Phase I Program 
  • One of 20 national BMT CTN (Bone Marrow Transplant Clinical Trials Network) Core Sites
  • Leading National Genomic Sequencing Program 
  • Inventor of MIBG Therapy for Neuroblastoma
  • National leaders in basic science research in:

     - Genomic sequencing 
     - Bleeding/thrombotic disorders 
     - Neuro-oncology 
     - Nanotechnology 
     - Transplant immunobiology 
     - Cancer Immunotherapy 
     - Sarcoma translational research 

  • Faculty with national and international reputations as principal investigators in COG, PBMTC and BMT CTN studies and with leadership positions in COG, PBMTC and CIBMTR
  • Non-malignant stem cell transplants for conditions such as sickle cell anemia, congenital neutropenia and other immune deficiencies 
  • Immunohematology Program run through Pediatric Hematology/Oncology and Bone Marrow Transplant

Eligibility and Selection

Pediatric Hematology/Oncology adheres to the Graduate Medical Education policy of House Officer Selection. 

How to Apply

Thank you for your interest in the University of Michigan's Pediatric Hematology/Oncology Fellowship Program. Applications are accepted through ERAS.

The Department of Pediatrics offers a Fellow Applicant Travel Scholarship Program for applicants interested in cell and molecular biology and health disparities research.

Supervision Policy

Pediatric Hematology/Oncology complies with the University of Michigan Graduate Medical Education supervision policy. 

Global Clinical Program Trainee (Resident) Supervision Policy